BLISS GVS PHARMA
|
BLISS GVS PHARMA Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
Equity - Authorised | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
Equity - Issued | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
Equity Paid Up | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | ₹7.73 Cr | ₹8.90 Cr | ₹9.94 Cr | ₹9.84 Cr | - |
Total Reserves | ₹949 Cr | ₹865 Cr | ₹798 Cr | ₹788 Cr | ₹725 Cr |
Securities Premium | ₹33 Cr | ₹27 Cr | ₹21 Cr | ₹15 Cr | ₹15 Cr |
Capital Reserves | ₹-0.73 Cr | - | - | - | - |
Profit & Loss Account Balance | ₹887 Cr | ₹815 Cr | ₹749 Cr | ₹737 Cr | ₹673 Cr |
General Reserves | ₹45 Cr | ₹45 Cr | ₹45 Cr | ₹45 Cr | ₹45 Cr |
Other Reserves | ₹-16 Cr | ₹-23 Cr | ₹-17 Cr | ₹-9.30 Cr | ₹-8.25 Cr |
Reserve excluding Revaluation Reserve | ₹949 Cr | ₹865 Cr | ₹798 Cr | ₹788 Cr | ₹725 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹967 Cr | ₹884 Cr | ₹819 Cr | ₹808 Cr | ₹736 Cr |
Minority Interest | ₹36 Cr | ₹34 Cr | ₹28 Cr | ₹20 Cr | ₹15 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹36 Cr | ₹41 Cr | ₹23 Cr | ₹33 Cr | ₹37 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹55 Cr | ₹52 Cr | ₹23 Cr | ₹53 Cr | ₹37 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-19 Cr | ₹-11 Cr | - | ₹-21 Cr | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹3.59 Cr | ₹-3.33 Cr | ₹1.32 Cr | ₹8.21 Cr | ₹3.56 Cr |
Deferred Tax Assets | ₹26 Cr | ₹22 Cr | ₹13 Cr | ₹3.59 Cr | ₹3.57 Cr |
Deferred Tax Liability | ₹29 Cr | ₹19 Cr | ₹14 Cr | ₹12 Cr | ₹7.13 Cr |
Other Long Term Liabilities | ₹9.34 Cr | ₹2.79 Cr | ₹3.58 Cr | ₹1.93 Cr | ₹3.09 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹2.54 Cr | ₹2.69 Cr | ₹1.07 Cr | ₹2.50 Cr | ₹2.44 Cr |
Total Non-Current Liabilities | ₹51 Cr | ₹43 Cr | ₹29 Cr | ₹45 Cr | ₹46 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹61 Cr | ₹86 Cr | ₹93 Cr | ₹74 Cr | ₹90 Cr |
Sundry Creditors | ₹61 Cr | ₹86 Cr | ₹93 Cr | ₹74 Cr | ₹90 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹65 Cr | ₹58 Cr | ₹68 Cr | ₹54 Cr | ₹57 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹6.58 Cr | ₹3.15 Cr | ₹8.73 Cr | ₹16 Cr | ₹23 Cr |
Interest Accrued But Not Due | ₹0.12 Cr | ₹0.06 Cr | ₹0.16 Cr | ₹0.32 Cr | ₹0.37 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹58 Cr | ₹55 Cr | ₹59 Cr | ₹38 Cr | ₹34 Cr |
Short Term Borrowings | ₹32 Cr | ₹46 Cr | ₹61 Cr | ₹65 Cr | ₹66 Cr |
Secured ST Loans repayable on Demands | ₹27 Cr | ₹31 Cr | ₹45 Cr | ₹49 Cr | ₹66 Cr |
Working Capital Loans- Sec | ₹27 Cr | ₹31 Cr | ₹45 Cr | ₹49 Cr | ₹66 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-22 Cr | ₹-15 Cr | ₹-29 Cr | ₹-32 Cr | ₹-66 Cr |
Short Term Provisions | ₹1.87 Cr | ₹2.66 Cr | ₹12 Cr | ₹11 Cr | ₹17 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹1.87 Cr | ₹2.66 Cr | ₹6.65 Cr | ₹8.60 Cr | ₹9.86 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | - | - | ₹5.28 Cr | ₹2.09 Cr | ₹7.15 Cr |
Total Current Liabilities | ₹160 Cr | ₹193 Cr | ₹233 Cr | ₹204 Cr | ₹231 Cr |
Total Liabilities | ₹1,214 Cr | ₹1,154 Cr | ₹1,109 Cr | ₹1,077 Cr | ₹1,027 Cr |
ASSETS | |||||
Gross Block | ₹468 Cr | ₹459 Cr | ₹343 Cr | ₹285 Cr | ₹276 Cr |
Less: Accumulated Depreciation | ₹98 Cr | ₹81 Cr | ₹63 Cr | ₹51 Cr | ₹35 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹369 Cr | ₹378 Cr | ₹281 Cr | ₹234 Cr | ₹241 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹7.83 Cr | ₹2.80 Cr | ₹22 Cr | ₹2.40 Cr | - |
Non Current Investments | ₹3.61 Cr | ₹2.84 Cr | ₹2.39 Cr | ₹0.01 Cr | ₹0.72 Cr |
Long Term Investment | ₹3.61 Cr | ₹2.84 Cr | ₹2.39 Cr | ₹0.01 Cr | ₹0.72 Cr |
Quoted | - | ₹0.51 Cr | ₹2.15 Cr | - | - |
Unquoted | ₹3.61 Cr | ₹2.33 Cr | ₹0.24 Cr | ₹0.01 Cr | ₹0.72 Cr |
Long Term Loans & Advances | ₹16 Cr | ₹18 Cr | ₹24 Cr | ₹13 Cr | ₹15 Cr |
Other Non Current Assets | ₹4.50 Cr | ₹54 Cr | ₹1.47 Cr | ₹62 Cr | ₹1.24 Cr |
Total Non-Current Assets | ₹402 Cr | ₹456 Cr | ₹332 Cr | ₹312 Cr | ₹257 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹0.56 Cr | ₹4.96 Cr | - | - | - |
Quoted | ₹0.56 Cr | ₹4.96 Cr | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹118 Cr | ₹103 Cr | ₹124 Cr | ₹99 Cr | ₹74 Cr |
Raw Materials | ₹53 Cr | ₹47 Cr | ₹41 Cr | ₹46 Cr | ₹37 Cr |
Work-in Progress | ₹6.30 Cr | ₹4.44 Cr | ₹8.23 Cr | ₹3.34 Cr | ₹5.10 Cr |
Finished Goods | ₹22 Cr | ₹18 Cr | ₹35 Cr | ₹32 Cr | ₹21 Cr |
Packing Materials | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹14 Cr | ₹11 Cr |
Stores  and Spare | ₹2.26 Cr | ₹3.01 Cr | ₹2.58 Cr | ₹2.72 Cr | ₹1.91 Cr |
Other Inventory | ₹18 Cr | ₹16 Cr | ₹22 Cr | ₹1.10 Cr | ₹-2.47 Cr |
Sundry Debtors | ₹404 Cr | ₹385 Cr | ₹393 Cr | ₹464 Cr | ₹548 Cr |
Debtors more than Six months | ₹33 Cr | ₹67 Cr | ₹58 Cr | ₹179 Cr | ₹3.80 Cr |
Debtors Others | ₹407 Cr | ₹354 Cr | ₹350 Cr | ₹294 Cr | ₹550 Cr |
Cash and Bank | ₹216 Cr | ₹103 Cr | ₹178 Cr | ₹145 Cr | ₹103 Cr |
Cash in hand | ₹0.07 Cr | ₹0.09 Cr | ₹0.05 Cr | ₹0.11 Cr | ₹0.06 Cr |
Balances at Bank | ₹216 Cr | ₹103 Cr | ₹177 Cr | ₹144 Cr | ₹103 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹17 Cr | ₹6.63 Cr | ₹14 Cr | ₹18 Cr | ₹16 Cr |
Interest accrued on Investments | ₹10 Cr | ₹3.40 Cr | ₹9.17 Cr | ₹6.66 Cr | ₹2.57 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | ₹3.29 Cr | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹2.78 Cr | ₹2.42 Cr | ₹3.19 Cr | ₹1.43 Cr | ₹1.66 Cr |
Other current_assets | ₹0.87 Cr | ₹0.81 Cr | ₹1.76 Cr | ₹9.46 Cr | ₹12 Cr |
Short Term Loans and Advances | ₹56 Cr | ₹95 Cr | ₹69 Cr | ₹40 Cr | ₹28 Cr |
Advances recoverable in cash or in kind | ₹18 Cr | ₹52 Cr | ₹54 Cr | ₹21 Cr | ₹17 Cr |
Advance income tax and TDS | ₹2.92 Cr | ₹1.62 Cr | ₹1.08 Cr | ₹1.46 Cr | ₹0.48 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹35 Cr | ₹41 Cr | ₹14 Cr | ₹18 Cr | ₹10 Cr |
Total Current Assets | ₹812 Cr | ₹697 Cr | ₹777 Cr | ₹765 Cr | ₹770 Cr |
Net Current Assets (Including Current Investments) | ₹652 Cr | ₹504 Cr | ₹544 Cr | ₹562 Cr | ₹539 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹1,214 Cr | ₹1,154 Cr | ₹1,109 Cr | ₹1,077 Cr | ₹1,027 Cr |
Contingent Liabilities | ₹57 Cr | ₹12 Cr | ₹23 Cr | ₹30 Cr | ₹14 Cr |
Total Debt | ₹88 Cr | ₹98 Cr | ₹105 Cr | ₹119 Cr | ₹121 Cr |
Book Value | 91.65 | 84.01 | 78.01 | 77.41 | 71.32 |
Adjusted Book Value | 91.65 | 84.01 | 78.01 | 77.41 | 71.32 |
Compare Balance Sheet of peers of BLISS GVS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BLISS GVS PHARMA | ₹1,227.4 Cr | -7.7% | -6.9% | 0.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,394.0 Cr | -6.7% | 2.6% | 5% | Stock Analytics | |
DIVIS LABORATORIES | ₹142,920.0 Cr | -6.6% | -3.7% | 43.8% | Stock Analytics | |
CIPLA | ₹114,383.0 Cr | -5.3% | -2.9% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,817.0 Cr | -3.8% | 1.8% | 25.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹91,385.4 Cr | -4.9% | -3.3% | -10.2% | Stock Analytics |
BLISS GVS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BLISS GVS PHARMA | -7.7% |
-6.9% |
0.2% |
SENSEX | -3.6% |
-0.7% |
-0.5% |
You may also like the below Video Courses